Premium
The reliability and success of peritoneal dialysis during the COVID‐19 pandemic
Author(s) -
Yeter Hasan H.,
Gok Oguz Ebru,
Akcay Omer F.,
Karaer Refika,
Yasar Emre,
Duranay Murat,
Ayli Mehmet D.,
Guz Galip
Publication year - 2020
Publication title -
seminars in dialysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.899
H-Index - 78
eISSN - 1525-139X
pISSN - 0894-0959
DOI - 10.1111/sdi.12940
Subject(s) - medicine , peritoneal dialysis , continuous ambulatory peritoneal dialysis , anxiety , parathyroid hormone , depression (economics) , dialysis , hemodialysis , population , covid-19 , observational study , pandemic , disease , calcium , psychiatry , environmental health , infectious disease (medical specialty) , economics , macroeconomics
Abstract We evaluated the symptoms, changes in laboratory findings during the novel coronavirus disease (COVID‐19) pandemic, and the effect of depression in patients with peritoneal dialysis (PD). This is an observational and cross‐sectional study. All patients were asked to fill the clinical assessment form and Beck depression and anxiety inventory. Also, the last two laboratory evaluations during this period were examined. A total of 123 patients performing PD were included. None of the patients were diagnosed with COVID‐19. In the total study population, parathyroid hormone (PTH), serum albumin, phosphorus and ferritin levels significantly elevated at the end of 97 ± 31 days. PTH and phosphorus levels remained stable in remote monitoring automated PD (RM‐APD) group ( p = 0.4 and p = 0.5), they tended to increase in continuous ambulatory PD group and significantly increased in automated PD group ( p = 0.09 and p = 0.01 for PTH and p = 0.06 and p = 0.001 for phosphorus, respectively). Moderate to severe depression was associated with dyspnoea, weight gain more than 5 kg, fatigue, palpitation and increased anxiety. PD is a reliable and successful form of dialysis and can be safely administered even if hospital access is restricted. Also, RM‐APD may be a better choice because of providing more stable bone‐mineral metabolism. Moreover, evaluating depression and anxiety is essential for the accurate clinical assessment.